Treatment of Sepsis Due to Gram-Negative Bacteria
The recommended first-line treatment for sepsis due to gram-negative bacteria is broad-spectrum antimicrobial therapy with a combination of antibiotics including an antipseudomonal beta-lactam (such as piperacillin-tazobactam, cefotaxime, or ceftriaxone) plus an aminoglycoside (such as gentamicin) administered within one hour of recognition of sepsis. 1, 2
Initial Empiric Therapy
First-line options:
- Combination therapy for initial management:
Second-line options:
Rationale for Combination Therapy
- Combination therapy provides broader coverage against common gram-negative pathogens (Enterobacteriaceae, Pseudomonas aeruginosa) 1, 3
- Reduces the risk of inappropriate initial antimicrobial therapy, which is associated with increased mortality 4
- Particularly important for septic shock, where the Surviving Sepsis Campaign suggests empiric combination therapy using at least two antibiotics of different classes 1
Timing and Administration
- Administer effective antimicrobials within the first hour of recognition of sepsis or septic shock 2
- Obtain blood cultures before starting antibiotics (if no significant delay <45 minutes) 2
- Use appropriate dosing strategies based on pharmacokinetic/pharmacodynamic principles 1
Source Control
- Identify and address the source of infection within 12 hours 2
- Remove infected devices (e.g., catheters) after establishing alternative access 2
De-escalation Strategy
- Reassess antimicrobial regimen daily for potential de-escalation 2
- Narrow therapy once pathogen identification and sensitivities are established (typically within 48-72 hours) 1
- De-escalate combination therapy within the first few days in response to clinical improvement 1
Duration of Therapy
- Standard duration: 7-10 days for most serious infections 1, 2
- Consider shorter courses (5-7 days) with rapid clinical resolution and adequate source control 2
- Consider longer courses for:
Special Considerations
- For suspected intra-abdominal infection: rapid restoration of intravascular volume and immediate antibiotics 2
- For pyelonephritis with sepsis: third-generation cephalosporins or piperacillin-tazobactam 2
- Consider local resistance patterns when selecting empiric therapy 1, 2
- Monitor procalcitonin levels to guide duration of antimicrobial therapy 1, 2
Common Pitfalls to Avoid
- Delayed administration of antibiotics - Each hour delay increases mortality by approximately 8% 5
- Inadequate spectrum of coverage - Ensure coverage of all likely pathogens based on suspected source 1
- Failure to adjust for local resistance patterns - Consider hospital and community antibiograms 1
- Neglecting source control - Source control is as important as appropriate antibiotics 2
- Prolonged combination therapy - Continue combination therapy only when clinically indicated; de-escalate when appropriate 1
The evidence strongly supports early, appropriate antimicrobial therapy as one of the most critical interventions for improving outcomes in gram-negative sepsis, with combination therapy providing the best chance of appropriate initial coverage 4, 5.